HyTdb

D-4-6

Hyt-057 | Adamantane | Published 2024.03.26

Basic Information

RU59063
Linker
POIAR — Androgen Receptor(AR)
Degradation PathwayUbiquitin-Proteasome Pathway
Published2024.03.26

Remarks

Chemical Identifiers

SMILESCC(C(N(C1=S)C2=CC=C(C#N)C(C(F)(F)F)=C2)=O)(N1CCCC(N3CCN(CCCCCC(NC45C[C@H](C[C@@H]6C5)C[C@H](C6)C4)=O)CC3)=O)C
Molecular FormulaC37H49F3N6O3S
InChIInChI=1S/C37H49F3N6O3S/c1-35(2)33(49)46(29-10-9-28(24-41)30(20-29)37(38,39)40)34(50)45(35)12-6-8-32(48)44-15-13-43(14-16-44)11-5-3-4-7-31(47)42-36-21-25-17-26(22-36)19-27(18-25)23-36/h9-10,20,25-27H,3-8,11-19,21-23H2,1-2H3,(H,42,47)/t25-,26+,27-,36?
InChI KeyRSIWDWNGMHQTDS-KGGVVWLGSA-N
IUPAC Name/
PubChem CID/

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILES
Tag ClogP5.022
HydrophobicityHigh(ClopP>5)

Mechanism of Action

POI (Protein of Interest)

POI NameAndrogen Receptor(AR)
GeneAR
UniProt IDP10275

Amino Acid Sequence

MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ

3D Structure (/structures/AF-P10275-F1-model_v6.cif)

Loading /structures/AF-P10275-F1-model_v6.cif …

Function

Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation. Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3

Degradation Pathway

Activity Data

TypeDC50
Value<5μM
POI NameAR
Cell LineLNCaP
Cell Line IDCVCL_0395
Assay MethodWB
Reference10.1016/j.bioorg.2024.107309

Description

We evaluated the ability of all compounds to induce AR degradation in LNCaP cells (human prostate cancer cells with AR high expression) at 5 μM with a 24 h treatment time by Western Blot. The smaller the ratio of AR protein content to the control group after drug treatment, the stronger the protein degradation ability of the drug. As shown in Fig. 6, a few of the 48 compounds showed good AR protein degradation ability. Compound D-3–6, D-4–6 and D-B-8 showed more than 50 % degrada tion capacity of AR protein, which were 55 %, 57 % and 58 % respectively.

TypeIC50
Value4.77 ± 0.26 μM
POI NameAR
Cell LineLNCaP
Cell Line IDCVCL_0395
Assay MethodMTT assay
Reference10.1016/j.bioorg.2024.107309

Description

5) Compound D-3–6 and D-4–6 showed moderate AR degradation effect and anti-prostate cancer activity against LNCaP cells with IC50 of 5.11 μM and 4.77 μM respectively, which was superior to enzalutamide.

Disease Information

DiseaseICD-11Source
Prostate carcinoma2C82.YCell Line Origin
Complete Androgen Insensitivity SyndromeLD2A.4Gene-Disease Association
Kennedy disease8B61.4Gene-Disease Association
Partial androgen InsensitivityLD2A.4Gene-Disease Association
Androgen Insensitivity SyndromeLD2A.4Gene-Disease Association
Male InfertilityGB04Gene-Disease Association
Prostate Cancer2C82Gene-Disease Association
Adenocarcinoma2D40Gene-Disease Association
Endometrial Cancer2C76Gene-Disease Association
Ovarian Cancer2C73Gene-Disease Association